Conjugate of Doxorubicin to Albumin‐Binding Peptide Outperforms Aldoxorubicin
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Conjugate of Doxorubicin to Albumin‐Binding Peptide Outperforms Aldoxorubicin
Authors
Keywords
-
Journal
Small
Volume 15, Issue 12, Pages 1804452
Publisher
Wiley
Online
2019-02-13
DOI
10.1002/smll.201804452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Fusion of fibroblast growth factor 21 to a thermally responsive biopolymer forms an injectable depot with sustained anti-diabetic action
- (2018) Caslin A. Gilroy et al. JOURNAL OF CONTROLLED RELEASE
- Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
- (2018) Eric M. Mastria et al. JOURNAL OF CONTROLLED RELEASE
- Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude
- (2018) Jacob S. Brenner et al. Nature Communications
- Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas
- (2018) Jun Gong et al. Drug Design Development and Therapy
- A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy
- (2018) Lingling Shan et al. Theranostics
- Hydrazone linkages in pH responsive drug delivery systems
- (2017) Sandeep J. Sonawane et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes
- (2017) Mauro Cataldi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Albumin Binding Domain Fusing R/K-X-X-R/K Sequence for Enhancing Tumor Delivery of Doxorubicin
- (2017) Liping Liu et al. MOLECULAR PHARMACEUTICS
- Niclosamide-conjugated polypeptide nanoparticles inhibit Wnt signaling and colon cancer growth
- (2017) Jayanta Bhattacharyya et al. Nanoscale
- Screening: In the blood
- (2017) Cassandra Willyard NATURE
- Zika Virus and the Blood Supply: What Do We Know?
- (2017) Alexandra Jimenez et al. TRANSFUSION MEDICINE REVIEWS
- Discovery and technology for human health
- (2017) Nature Biomedical Engineering
- The Role of Micelle Size in Tumor Accumulation, Penetration, and Treatment
- (2015) Jinqiang Wang et al. ACS Nano
- The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
- (2015) Jonathan T. Sockolosky et al. ADVANCED DRUG DELIVERY REVIEWS
- Stable Evans Blue Derived Exendin-4 Peptide for Type 2 Diabetes Treatment
- (2015) Yi Liu et al. BIOCONJUGATE CHEMISTRY
- Anthracyclines potentiate anti-tumor immunity: A new opportunity for chemoimmunotherapy
- (2015) Zhigang Zhang et al. CANCER LETTERS
- A paclitaxel-loaded recombinant polypeptide nanoparticle outperforms Abraxane in multiple murine cancer models
- (2015) Jayanta Bhattacharyya et al. Nature Communications
- The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration
- (2015) Yong-Bo Hu et al. Translational Neurodegeneration
- Co-opting biology to deliver drugs
- (2014) Parisa Yousefpour et al. BIOTECHNOLOGY AND BIOENGINEERING
- The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior
- (2014) Huile Gao et al. Expert Opinion on Drug Delivery
- A clinical update of using albumin as a drug vehicle — A commentary
- (2014) Felix Kratz JOURNAL OF CONTROLLED RELEASE
- Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants
- (2014) R D Christensen et al. Journal of Perinatology
- The effect of the neonatal Fc receptor on human IgG biodistribution in mice
- (2014) Nancy Chen et al. mAbs
- Unraveling the mysteries of serum albumin—more than just a serum protein
- (2014) Angelica M. Merlot et al. Frontiers in Physiology
- Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells
- (2013) Aaron C. Anselmo et al. ACS Nano
- Human serum albumin from recombinant DNA technology: Challenges and strategies
- (2013) Zhen Chen et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Acidity Generated by the Tumor Microenvironment Drives Local Invasion
- (2013) V. Estrella et al. CANCER RESEARCH
- The thiol pool in human plasma: The central contribution of albumin to redox processes
- (2013) Lucía Turell et al. FREE RADICAL BIOLOGY AND MEDICINE
- Site-Specific Radiometal Labeling and Improved Biodistribution Using ABY-027, A Novel HER2-Targeting Affibody Molecule-Albumin-Binding Domain Fusion Protein
- (2013) A. Orlova et al. JOURNAL OF NUCLEAR MEDICINE
- THE ALBUMIN-BINDING DOMAIN AS A SCAFFOLD FOR PROTEIN ENGINEERING
- (2013) Johan Nilvebrant et al. Computational and Structural Biotechnology Journal
- Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
- (2011) S. R. Mattarollo et al. CANCER RESEARCH
- Endosome maturation
- (2011) Jatta Huotari et al. EMBO JOURNAL
- Tumor delivery of macromolecular drugs based on the EPR effect
- (2010) Vladimir Torchilin ADVANCED DRUG DELIVERY REVIEWS
- Adriamycin Nephropathy
- (2010) Kaoru Yasuda et al. AMERICAN JOURNAL OF PATHOLOGY
- Recursive Directional Ligation by Plasmid Reconstruction Allows Rapid and Seamless Cloning of Oligomeric Genes
- (2010) Jonathan R. McDaniel et al. BIOMACROMOLECULES
- Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
- (2010) J. Löfblom et al. FEBS LETTERS
- Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
- (2010) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cardiomyocyte death in doxorubicin-induced cardiotoxicity
- (2009) Yi-Wei Zhang et al. ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS
- Doxorubicin Cardiomyopathy
- (2009) Kanu Chatterjee et al. CARDIOLOGY
- Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU)
- (2009) M. Marre et al. DIABETIC MEDICINE
- Nanoparticle-based targeted drug delivery
- (2009) Rajesh Singh et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- INNO-206, the (6-maleimidocaproyl hydrazone derivative of doxorubicin), shows superior antitumor efficacy compared to doxorubicin in different tumor xenograft models and in an orthotopic pancreas carcinoma model
- (2009) R. Graeser et al. INVESTIGATIONAL NEW DRUGS
- Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injection
- (2009) J. Andrew MacKay et al. NATURE MATERIALS
- Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
- (2008) Felix Kratz JOURNAL OF CONTROLLED RELEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More